CA9 and renal cell carcinoma: By immunohistochemical (IHC) analysis of clinical RCC specimens, we recently found two surface biomarkers, carbonic anhydrase 9 (CA9) and CD147, which show excellent features as candidate capture antigens for RCC CTCs.